Given that the placental-specific transcript of KCNH5 has been detected in melanoma [26], [27], we aimed to investigate whether its retrotransposon-derived promoter, which is hypermethylated in those studied normal tissues from the body [18], becomes hypomethylated in melanoma. This evidence concerns the gene KCNH5 and melanoma.